Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2 -agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

The Lancet (British edition), 2016-10, Vol.388 (10056), p.2115-2127 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31324-1

Full text available